Walleye Trading’s Wave Life Sciences WVE Stock Holding History

Walleye Trading’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$64.5K	Buy	8,900 +2,200	+33%	+$28.7K	﹤0.01%	3611
2025 Q4	$114K	Sell	6,700 -9,200	-58%	-$93.5K	﹤0.01%	3678
2025 Q3	$116K	Buy	+15,900	New	+$129K	﹤0.01%	3649
2022 Q1	–	Sell	-6,800	Closed	-$21K	–	5972
2021 Q4	$21K	Buy	+6,800	New	+$28.2K	﹤0.01%	4921
2021 Q1	–	Sell	-12,800	Closed	-$101K	–	5374
2020 Q4	$101K	Buy	+12,800	New	+$107K	﹤0.01%	3929
2020 Q3	–	Sell	-59,400	Closed	-$618K	–	4688
2020 Q2	$618K	Sell	59,400 -13,100	-18%	-$123K	﹤0.01%	2086
2020 Q1	$679K	Buy	+72,500	New	+$618K	0.01%	1612
2019 Q3	–	Sell	-5,700	Closed	-$149K	–	4492
2019 Q2	$149K	Buy	+5,700	New	+$160K	﹤0.01%	3129

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

GSK plc London $599M AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Walleye Trading's WVE Position: Q1 2026 in Review

Walleye Trading reduced its Wave Life Sciences (WVE) stake by 51% in Q1 2026, selling an estimated $221K and leaving 16,288 shares worth $118K. The position accounts for ﹤0.01% of the portfolio, ranked #3387.

Walleye Trading first reported a position in WVE in Q4 2020 and has held it in 5 quarters since. The position peaked at $565K in Q4 2025. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

Walleye Trading held 16,288 shares of Wave Life Sciences worth $118K as of Q1 2026.
Walleye Trading sold 16,953 Wave Life Sciences shares in Q1 2026, an estimated $221K.
Wave Life Sciences made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #3387 holding.
Walleye Trading first reported a position in Wave Life Sciences in Q4 2020 and has held it in 5 quarters since.
Walleye Trading's Wave Life Sciences position peaked at $565K in Q4 2025.
230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.